Evidence map›Paper›PMID 35321958›Full record

ArticleGut and liver2022

Changing Patterns of Causative Pathogens over Time and Efficacy of Empirical Antibiotic Therapies in Acute Cholangitis with Bacteremia.

Han Taek Jeong, Jeong Eun Song, Ho Gak Kim, Jimin Han

Open access · diamondAbstract read
In one paragraph

Article in Gut and liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Predictive value of platelet count-related ratios for severity in biliary Escherichia coli and Klebsiella pneumonia bloodstream infections.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. Article
  4. Article
  5. Epidemiology of biliary tract-associated bloodstream infections and adequacy of empiric therapy: an Australian population-based study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Han Taek JeongDepartment of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.ORCID 0000-0001-9246-3819
Jeong Eun SongDepartment of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.ORCID 0000-0002-1034-4478
Ho Gak KimDepartment of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.ORCID 0000-0003-3365-1662
Jimin HanDepartment of Internal Medicine, Daegu Catholic University School of Medicine, Daegu, Korea.ORCID 0000-0001-8674-370X
Daegu Catholic University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: To select appropriate empirical antibiotics, updates on the changes in pathogens are essential. We aimed to investigate the changes in pathogens and their antibiotic susceptibility in acute cholangitis (AC) with bacteremia over a period of 15 years. Furthermore, the efficacy of empirical antibiotic therapies and the risk factors predicting antibiotic-resistant pathogens (ARPs) were analyzed. Methods: A total of 568 patients with AC and bacteremia who were admitted to Daegu Catholic University Medical Center from January 2006 to December 2020 were included. Their medical records were retrospectively reviewed. In addition, the data were grouped and analyzed at 3-year intervals under the criteria of Tokyo Guideline 2018. Results: During the study period, 596 pathogens were isolated from blood cultures of 568 patients. The three most common pathogens were Conclusions: The proportion of VRE has increased and CRE has emerged in AC. In addition, healthcare-associated infection, history of previous biliary intervention, and the severity of AC were independent risk factors predicting ARP. For patients with these risk factors, the administration of imipenem or piperacillin-tazobactam should be considered.

Indexed as

BacteremiaCholangitisAnti-Bacterial AgentsHumansImipenemMicrobial Sensitivity TestsPiperacillin, Tazobactam Drug CombinationRetrospective StudiesAnti-Bacterial AgentsImipenemPiperacillin, Tazobactam Drug CombinationAnti-bacterial agentsBacteremiaCarbapenem-resistantCholangitisDrug resistancemicrobial

Identifiers

PMID35321958
PMCPMC9668498
OpenAlexW4220773635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.